Featured
Read our handpicked blogs, curated for you.
|
The Fundamentals of Zero-Downtime UpgradesUpgrading legacy HIS without downtime relies on parallel running, strangler…
|
Low risk approaches favor incremental strategies over big-bang replacements. Common tactics include rehosting to cloud…
|
Legacy hospital information systems often run on outdated languages like COBOL or MUMPS. They support core functions…
Recent releases
|
Adherence = Revenue: The Data Case Pharma CMOs Can’t Afford to Miss
Why Adherence is the Real Growth Lever: Let’s call it straight. For all the money pharma spends on marketing, the biggest gap isn’t awareness. It’s adherence. Doctors prescribe. Patients start. But…
|
Pharma Marketing Relevance Transforming Doctor Engagement
Why Pharma Marketing Relevance Matters More Than EverField forces once drove brand recall. That edge has dulled. Doctors see 10–12 reps a day, often pushing near-identical drugs. No surprise they cut…
|
Why CRMs Fail Pharma, and How Tech-Led Marketing Reclaims ROI
The Broken Promise of CRM in Pharma MarketingFor years, CRM in pharma marketing was sold as the silver bullet. Buy the system, train the reps, and suddenly you’d have airtight engagement with doctors…
|
Why Your Omnichannel Marketing Is Just Noise, And How to Fix It
We analyzed 20 pharma websites and spoke with 10 CMOs and digital leads from mid-to-large pharma brands across India. Almost everyone said the same thing. "We're spending on omnichannel HCP…
